[The mortality rate and medical costs identified by a national health examination analysis]
Jee SH, Ahn J, Lee JY, Yoon M, Jung KJ, Mok Y, Lee SJ, Lim J
Record ID 32014001101
Korean
Original Title:
국가 일반건강검진의 사망률과 의료비 지출에 대한 영향분석
Authors' recommendations:
The occurrence, mortality risk, and medical cost expenditures of target group 1 with atherosclerotic cardiovascular disease, ischemic heart disease, stroke, and all-cancer were determined by the number of health examinations conducted between 1992 and 2000 (i.e., 1-2, 3-4, and ≥5 times). We additionally analyzed the occurrence and mortality risk of target group 2 with atherosclerotic cardiovascular disease, ischemic heart disease, stroke, and all-cancer using the period between the year in which the last examination was conducted and 2011.
For both target group 1 and 2, the risk of diseases increased among both genders who had their health examinations more frequently, and participants who had their health examination more than five times showed lower mortality risk than those who had not. The average medical cost of target group 1 decreased as the frequency of health examination increased (>5 times). This trend was more obvious in women.
Implementation of the national health examination has had a positive effect on mortality risk and health cost, with both decreasing as the number of health examinations increased. Further studies are warranted concerning the association of health examination with preventive effect of disease incidence.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www.neca.re.kr/lay1/program/S1T11C145/report/view.do?seq=112
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
South Korea
MeSH Terms
- Mortality
- Costs and Cost Analysis
- Mass Screening
Contact
Organisation Name:
National Evidence-based healthcare Collaborating Agency
Contact Address:
National Evidence-based Healthcare Collaborating Agency (NECA), 3~5F Health and Welfare Social Administration B/D, 400 Neungdong-ro, Gwangjin-gu, Seoul, Korea.
Contact Name:
int@neca.re.kr
Contact Email:
int@neca.re.kr
Copyright:
National Evidence-based Healthcare Collaborating Agency (NECA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.